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ABSTRACT
Huntington Disease (HD) is a neurodegenerative disorder that is caused by a CAG
trinucleotide repeat expansion in the huntingtin gene. The onset of the disease is defined by the
presence of motor deficits, such as chorea. However, cognitive and psychiatric symptoms often
develop before motor onset and typically have a larger impact on patient quality of life.
Psychiatric symptoms include depression, anxiety, and OCD, but also aggression and irritability,
which have been comparatively understudied due to stigma. Currently, treatments to modify
these behaviors in premanifest HD patients are not consistently effective and often have side
effects, creating a need for research into these psychiatric disturbances. Our lab has observed
increased-aggression in our humanized HD mouse model (Hu97/18) during routine handling that
is not present in our knock-in HD mouse model (Q175FDN). In this study, we seek to quantify
the aggressive behavior exhibited by these two mouse models and determine the neurological
basis for these observed behavioral differences. From this analysis, we seek to identify potential
therapeutic targets for modulating aggressive behavior in mice, which could lead to the
development of therapies that reduce the aggressive behavioral symptoms experienced by HD
patients.
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CHAPTER ONE: INTRODUCTION
Huntington Disease
Huntington Disease (HD) is a neurodegenerative disorder caused by a CAG repeat
expansion in the huntingtin (HTT) gene of greater than 35 [1]. Individuals with 36-39 CAG
repeats have reduced penetrance of HD, meaning they may never develop HD symptoms.
However, 40 or more CAG repeats is fully penetrant and affected individuals will develop HD
symptoms. Clinical diagnosis of HD is based on the presence of the CAG repeat expansion of 36
or more repeats combined with motor performance deficits on the Unified Huntington’s Disease
Ratings Scale (UHDRS), which is a standardized test used to assess motor and cognitive function
in HD patients. However, some HD patients develop cognitive and psychiatric symptoms prior
to motor symptoms. Psychiatric symptoms include depression, anxiety, aggression and
irritability [2, 3], and of these symptoms, aggression and irritability have been comparatively
understudied due to stigma. However, aggression and irritability have an extremely negative
impact on the quality of life for patients and caregivers, making it important to investigate and
characterize these aspects of HD [4].
Aggressive behavior is typically categorized as either pre-meditated or impulsive
aggression. Pre-mediated aggression is characterized by well-planned behavior that is not
associated with autonomic arousal or provocation [5]. However, impulsive aggression, also
called reactive aggression, is characterized by unplanned, emotionally-driven aggressive
episodes associated with autonomic arousal. Impulsive aggression becomes pathological when
the aggressive response is exaggerated compared to the initial provocation [5]. Previous studies
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seeking to characterize aggression displayed by HD patients found that verbal outbursts and
being easily irritated or impatient are common expressions of aggressive behavior [6, 7].
Additionally, it appears that the triggers for these aggressive episodes may be emotion-based,
such as frustration from changes in routine or requiring assistance from a caregiver, but
aggressive episodes may also appear without a clear antecedent event or trigger [8]. Based on
these previous findings, it is suggested that aggression in HD is pathological impulsive
aggression.
Neurological Basis for Aggression in HD
Previous studies have found that reduction in volume of the amygdala and ventromedial
hypothalamus may occur before HD onset [9-12]. Additionally, previous studies investigating
pathological reactive aggression have found that these structures are associated with aggression
[5, 13]. These findings suggest that these neurological structures may mediate pathological
aggression experienced by HD patients.
Amygdala
The amygdala is a small structure in the limbic system which mediates emotional
responses, such as fear or anger, in response to stimuli. Humans with pathological reactive
aggression tend to show hyperactivity of the amygdala [14, 15]. Medial amygdala lesioning in
mice reduces some aggressive behaviors, which is consistent with hyperactivation inducing
aggressive behavior [16]. However, hypoactivation of the amygdala in pre-HD patients
compared to gene-negative controls has been observed [17, 18]. Due to these conflicting
findings, the role of the amygdala in mediating HD-related aggression remains unclear.
2

Ventromedial Hypothalamus
The ventromedial hypothalamus (VMH) is a region in the hypothalamus that mediates
multiple functions in metabolism and behavior, but its precise role in aggression appears to be
unclear. Previous studies have found that hypothalamic dysfunction results in aggressive
behavior [19, 20]. Additionally, lesioning of the posterior or anterior regions of the VMH in rats
produces increased aggressive behavior [21]. However, other studies of aggressive behavior in
mice have found that inactivation of the VMH via a synthesized drug-receptor pair that
hyperpolarizes neurons, specifically in the ventrolateral portion, reduces aggressive behavior
[22]. However, the role of the VMH in HD-related aggression has not been explored.
Aggression Differences Observed in HD Model Mice
Our lab has observed that humanized HD model mice (Hu97/18) [23] demonstrate
increased aggression compared to the parent FVB/N (FVB) background strain, while knock-in
HD model mice (Q175FDN) [24] do not. However, this difference has not been quantified.
Additionally, the reason for this observed difference is unknown. Previous studies on aggression
have suggested multiple neurological targets may be involved in mediating aggressive behavior
in HD, including the amygdala and ventromedial hypothalamus. In this study, we have quantified
aggressive behavior exhibited by the two HD mouse models via multiple aggression behavioral
paradigms. We are now comparing the neurological targets in both mouse models through brain
dissection and immunohistochemistry to further elucidate the potential neurological differences
underlying the aggressive behavior differences. This study has furthered our understanding of the
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neurological basis of aggression in HD and could lead to the identification of therapeutic targets
for modulating aggression and irritability in HD.
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CHAPTER TWO: METHODOLOGY
Aggression Assays
In order to quantify the behavioral differences between the Hu97/18 and Q175FDN mice,
I have developed neutral home cage and resident-intruder aggression testing paradigms. In both
paradigms, an experimental mouse and a standard opponent mouse interact in a standard mouse
homecage. The experimental mice are single-housed at least one week prior to testing. Each test
lasts a maximum of 10 min, but violent behavior demonstrated by either mouse will end the test
prematurely. Each test occurs in the dark phase of a reversed light cycle under red light to reduce
anxiety and promote normal behavioral responses when mice are normally awake.
In the neutral homecage (NHC) assay, a standard opponent C57BL/6 (black 6) mouse is
introduced into a clean cage simultaneously with the experimental mouse. In the residentintruder (RI) assay, the test is performed in the homecage of the experimental mouse, and the
standard opponent is introduced as an intruder. Hu97/18, Hu18/18, Q175FDN, and FVB mice
were assessed in the two aggression testing paradigms using black 6 standard opponents as
fighting partners.
Scoring Aggression Assays
Aggressive behavior
Aggressive behavior was quantified based on latency to attack, the frequency of
aggressive behaviors, and the time in seconds spent engaging in aggressive behaviors during the
trial. Aggressive behaviors include clinch attack, keep down, and chase behavior (Figure 1). This
data is totaled and converted into three measures to evaluate the mouse in each test: attack time,
5

attack frequency, and attack latency. Attack time is calculated by dividing the time spent in
aggressive behaviors by the total time of the test to obtain a proportion of the time spent in
attack. Attack frequency is calculated by adding the total frequency of aggressive behaviors
exhibited in the test. Attack latency represents the amount of time passed before the mouse
exhibits a clinch attack.
A

B

C

Figure 1: Mice demonstrating different aggressive behaviors used to score the neutral
homecage and resident intruder assays A. A humanized HD mouse starting a “clinch attack” on the black
6 mouse, which consists of pushing or throwing the mouse and typically starts with a lunge or jump toward the other
mouse. B. A humanized HD mouse chasing the black 6 mouse. C. A humanized HD mouse exhibiting “keep down”
behavior, where the humanized HD mouse is holding down the black 6 mouse.

Violent Behavior
Violent behavior is defined as attacking vulnerable areas, including the face, genitals,
paws, and belly, or attack behaviors that draw blood. These attacks are forms of escalated
aggressive behaviors, and, for the safety of the mice, prematurely end the test. Violent behavior
6

is scored based on latency to violent behavior, which is the amount of time in seconds before a
mouse engages in these behaviors, as well as the percentage of mice who engage in violent
behaviors
Generation of Standard Opponents
Standard opponents for the tests are classified as dominant or submissive based on
baseline behavior displayed in the neutral home cage testing paradigm using only standard
opponents. Dominant behavior is based on the aggressive behavioral assessment described
above. Submissive behavior is based on latency to submissive posture, frequency of submissive
behavior, and time spent engaging in submissive behaviors. Submissive behaviors include
defensive upright posture, submissive posture, and flight (Figure 2).
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B

A

C

Figure 2: Mice demonstrating different submissive behaviors used to classify standard
opponents. A. The black 6 mouse on the left is demonstrating defensive upright posture, which is when the
mouse rears on its hind legs in response to an upright posture behavior from another mouse. B. The black 6 mouse
on the left is exhibiting submissive posture, which is when the mouse remains on the ground during a keep down or
clinch attack with their belly exposed and does not attempt to break away from the attack. C. The black 6 mouse on
the left is fleeing from the other mouse.

Classification as submissive or dominant is based on the aggression behavior score and
aggression time scores. The aggression behavior score is the ratio of average dominant behaviors
to average submissive behaviors exhibited in the standard opponent aggression testing. The
aggression time score is the ratio of time spent exhibiting aggressive behaviors to the total time
spent demonstrating any behavior. An aggression behavior score above 1 and an aggression time
score above 0.5 indicates the mouse is dominant. Each aggression testing paradigm is completed
twice such that each test mouse faces a dominant and submissive standard opponent.
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Figure 3: Classification of standard opponents as dominant or submissive. A. Dominant mice
exhibited significantly greater aggression behavior scores. B. Dominant mice exhibit significantly higher aggression
time scores. *=difference between indicated bars by unpaired t-test. * = p<0.05, ** = p<0.01. Error bars ±SEM

Brain Dissection and Immunohistochemistry
After aggression testing, the mice were perfused and brains were cut by cryostat into 25
µM free-floating coronal sections into a phosphate buffer solution at pH 7.4. In ongoing work, a
series of brain sections spanning the amygdala and VMH and spaced 200 µM apart are being
stained, and stereological volumetric assessments will be conducted. Using StereoInvestigator
software, the perimeters of the desired structures will be outlined. Then, the Cavalieri principle
will be utilized using section thickness, spacing, and structure area throughout the series to
determine the volume of the structure.
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Amygdala Stain
To stain the medial and basomedial amygdaloid structures, we are utilizing NADPH
staining, which has been previously shown to stain these structures in rat brains [25]. We will
utilize the protocol described in a previous study that sought to stain the central amygdala [26].
In brief, the free-floating sections are placed in a solution of 1mM β-NADPH (Sigma), 0.8 mM
nitro blue tetrazolium (Sigma), and 0.06% Triton X-100 in phosphate-buffered saline (PBS). The
slides are incubated for 1-2 hours at 37℃. Then, they are rinsed with cold PBS to stop the
reaction. The sections are then mounted on slides and dried overnight. Following a serial
dehydration and a clearing step utilizing xylenes, the slides are coverslipped using Permount
(Fisher) mounting medium.
VMH Stain
To stain for the VMH, are utilizing a Thionin stain that was described in a previous study
that conducted volumetric analysis of the VMH in rats [27]. The thionin staining protocol was
modified from an online protocol posted by the Kansas Intellectual and Developmental
Disabilities Research Center [28]. Briefly, sections are mounted on slides and stained with a
Thionin (Sigma) solution (consisting of 18 mL of 0.5% Thionin in distilled water, 180 mL of
distilled water, 9 mL of 1.0 M Sodium Acetate solution, and 21 mL 1.0 M Acetic Acid solution
at pH 4.3) for 20 minutes at 20℃. Following a serial dehydration and a clearing step utilizing
xylenes, the slides are then coverslipped with Permount (Fisher) mounting medium.
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CHAPTER THREE: RESULTS
Quantifying behavioral differences in aggression between Hu97/18 and Q175FDN mice
37 mice comprised of 9 Hu87/18, 9 Hu18/18, 10 Q175FDN +/- (heterozygous knock-in:
het) and 9 FVB, were utilized for the NHC and RI tasks. Two mice were found dead during the
experiment, and one mouse was euthanized for health reasons. This left 34 mice for behavioral
testing. After completing behavioral testing, we excluded data from one mouse that exhibited
erratic behavior. Additionally, we excluded data points for tests that lasted less than 1 min as
well as tests where the standard opponent engaged in violent behavior. After reviewing the
standard opponent and mouse behavior for abnormalities, we excluded additional tests that
utilized a standard opponent that was deemed hyper-aggressive and a FVB mouse who
demonstrated reactive behavior consistent with the naturally occurring FVB seizure disorder
[29]. This left data points for 32 mice in the NHC assay and 27 mice in the RI assay.
Neutral Homecage
Hu97/18 and Hu18/18 mice demonstrated similar aggressive behaviors in the neutral
homecage assay based on the attack time, attack frequency, and attack latency scores (Figure 4).
Both the Hu18/18 and Hu97/18 mice express human HTT transgenes and lack mouse Htt.
However, Hu18/18 mice express only WT human HTT, while Hu97/18 mice express both human
WT and mtHTT. Hu97/18 exhibit numerous HD-like phenotypes not present in Hu18/18 mice;
however, both Hu18/18 and Hu97/18 exhibit metabolic dysfunction and circadian rhythm
disruption. Based on this evidence that Hu18/18 mice may not be the most appropriate control
for Hu97/18 mice, we decided that the comparison between Hu97/18 and FVB mice was more
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relevant to investigate aggressive and non-aggressive HD behaviors. Thus, we have excluded
Hu18/18 mice in subsequent analysis.
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aggression examined.

Compared to FVB mice, Hu97/18 mice exhibited significantly greater proportional attack
times while Q175FDN mice did not (Figure 5A, 1 way ANOVA with Turkey’s multiple
comparisons test compared to FVB, Hu97/18 p=0.0002, Q175FDN p=0.8821). Additionally,
Hu97/18 mice exhibited greater proportional attack times compared to Q175FDN mice as well
(Figure 5A, 1 way ANOVA with Turkey’s multiple comparisons test compared to Q175FDN
mice, Hu97/18 p<0.0001). Additionally, Hu97/18 mice exhibited significantly shorter latencies
to clinch attack while Q175FDN did not when compared to FVB mice (Figure 5B, Hu97/18
p<0.0001, Q175FDN p=0.9015). Hu97/18 mice also exhibited shorter latencies to clinch attack
compared to Q175FDN mice, (Figure 5B, 1 way ANOVA with Turkey’s multiple comparisons
test compared to Q175FDN mice, Hu97/18 p<0.0001) Taken together, these data suggest
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heightened aggression in Hu97/18 mice compared to FVB or Q175FDN mice. Interestingly,
Hu97/18, FVB, and Q175FDN mice all displayed similar attack frequencies (Figure 5C,
Hu97/18 p=0.9507, Q175FDN p=0.8973), which may indicate similar motivations to engage in
aggressive behaviors. However, attack frequency encompasses all forms of aggressive behaviors
including violent behaviors, so it may be possible that the observed difference between Hu97/18
mice and the less aggressive Q175FDN and FVB mice may be related to the type of behaviors
exhibited rather than the frequency of these behaviors. Thus, the mice would all demonstrate
similar motivations in fight behaviors, but Hu97/18 mice may escalate aggressive behaviors and
engage in them for longer periods of time per attack.

ANOVA summary
F
18.71
P value
<0.0001

ANOVA summary
F
27.74
P value
<0.0001

8

8

7

7/
18

0

D
N

18
7/

10

u9

H

u9

20

H

N
D

30

17
5F

Q

5F
17

8

8

7

40

Q

B
FV

0

NHC Attack Frequency

FV
B

8

8

7

7/
18

0.0

200

u9

0.1

400

D
N

0.2

600

17
5F

0.3

***
* ****

C
Number of Attacks per Trial

800

Q

0.4

NHC Attack Latency

H

**
* ****

0.5

B
Attack Latency (sec)

Proportion of Time Spent in
Aggressive Behavior

NHC Attack Time

FV
B

A

ANOVA summary
F
0.1019
P value
0.9036

Figure 5: Hu97/18 mice demonstrate elevated aggression during the neutral homecage
assay. Mice were tested in NHC under red light in dark phase with a max trial duration of 10 min. A. Hu97/18
mice spent a significantly greater proportion of time engaging in aggressive behaviors compared to FVB mice, while
Q17F5DN mice behaved similar to FVB mice. B. Hu97/18 mice had significantly shorter attack latencies, latency to
engage in a ‘clinch’ attack, compared to FVB and Q175FDN mice. C. Attack frequency was not affected by
genotype. *=difference between indicated bars. ***= p<0.001, ****= p<0.0001. Error bars ±SEM
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Compared to FVB mice, only 14% of which engaged in violent behaviors, 75% of
Hu97/18 mice engaged in violent behaviors (Figure 6A), demonstrating dramatically elevated
severity of aggressive behaviors in Hu97/18 mice. Violent behaviors were not observed in
Q175FDN mice. Additionally, Hu97/18 mice had a significantly shorter latency to violent
behavior compared to FVB mice, while Q175FDN mice did not (Figure 6B, 1 way ANOVA with
Turkey’s multiple comparisons test compared to FVB, Hu97/18 p=0.0047, Q175FDN p=0.9098).
These data demonstrate that unlike Q175FDN HD mice, Hu97/18 humanized HD mice
recapitulate HD-related enhanced aggressive behaviors.
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Resident-Intruder
Compared to FVB mice, Hu97/18 and Q175FDN mice did not exhibit significantly
shorter latencies to clinch attack (Figure 7B, Hu97/18 p=0.1740, Q175FDN p=0.3814).
However, Hu97/18 mice did exhibit significantly shorter latency to clinch attack compared to
Q175FDN mice (Figure 7B, Q175FDN p=0.0150). Interestingly, unlike in the neutral homecage
assay, Hu97/18, FVB, and Q175FDN mice all displayed similar attack times (Figure 7A,
Hu97/18 p=0.9950, Q175FDN p=0.8595). Additionally, Hu97/18, FVB, and Q175FDN mice all
exhibited similar attack frequencies (Figure 7C, Hu97/18 p=0.9039, Q175FDN p=0.3785), which
remains consistent with results from the neutral homecage assay. Since similar attack frequencies
may indicate that the difference between Hu97/18 mice and the less aggressive Q175FDN and
FVB mice may be related to the type and duration of behaviors exhibited rather than the
frequency of these behaviors, violent behaviors were assessed again for this assay.
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Compared to FVB mice, of which 66.7% engaged in violent behaviors, 71.4% of
Hu97/18 mice and 40% in Q175FDN mice engaged in violent behaviors (Figure 8A). Hu97/18
mice had a similar percentage engaging in violent behaviors in both the NHC (75%) and RI
(71.4%) assays despite the fact that the RI test is considered more threatening. This indicates that
the Hu97/18 mice reacted similar to both the NHC and RI assay. Additionally, the reduction of
Q175FDN mice participating in violent behavior is consistent with the results found in the NHC
assay where 0% engaged in violent behavior, which is less than the 14% of FVB mice that did.
However, Hu97/18, Q175FDN, and FVB mice did not significantly differ in latency to violent
behaviors (Figure 8B, 1 way ANOVA with Turkey’s multiple comparisons test compared to
16

FVB, Hu97/18 p=0.9878, Q175FDN p=0.5494). Based on these data, Hu97/18 mice do not
exhibit elevated aggression during the RI assay.
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Figure 8: Hu97/18 mice do not exhibited elevated violent behavior in the resident-intruder
assay. Mice were tested in RI under red light in the animals dark phase with a max trial duration of 10 min. A.
Compared to FVB mice, a similar percentage of Hu97/18 mice engaged in violent behaviors and a smaller
percentage of Q175FDN mice engaged in violent behaviors. B. FVB, Q175FDN, and Hu97/18 mice did not
significantly differ on latency to violent behaviors. Error bars ±SEM
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CHAPTER FOUR: DISCUSSION AND FUTURE DIRECTIONS
Discussion
As expected the Hu97/18 mice demonstrated higher aggression scores during the NHC
task as indicated by the attack time and attack latency scores. Though attack frequency was not
significantly different, we did notice that a higher percentage of Hu97/18 mice engaged in
violent behaviors that ended the aggression testing, which indicates that Hu97/18 may exhibit a
greater number of violent behaviors rather than a greater number of overall aggressive behaviors.
However, Hu97/18 did not demonstrate higher aggression scores during the RI task. Violent
behaviors were not significantly different either for Hu97/18 mice compared to FVB and
Q175FDN mice. However, the Hu97/18 mice appeared to display similar behavior scores in both
the NHC and RI tests even though the RI assay is more stressful and should elicit higher
aggression. This data indicates that the increased aggressive phenotypes exhibited by Hu97/18
mice may be from finding both aggression tests equally as threatening, as exhibited by equally
reactive aggression in both settings. This suggests that HD-related aggression may be based on
overreaction.
The focus of the investigation into aggressive behavior will now shift to neurological
differences between the aggressive HD mice, Hu97/18, and the non-aggressive HD mice,
Q175FDN, as well as comparison of both to control mice. From this analysis, we seek to identify
neurological changes that correlate with the aggressive phenotype exhibited by the Hu97/18
mice. This information can be used to identify targets for therapies to reduce HD-related
aggressive symptoms in HD patients.
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Future Directions
In future studies, we will conduct volumetric analyses of the amygdala and VMH to see if
the volumes of these structures are correlated to the aggressive behaviors exhibited by HD mice.
Currently, brains have been collected and are being sectioned and stained. We expect that mice
demonstrating higher aggression will exhibit changes in volume of the VMH and amygdala.

Overall, we have found that our humanized HD model exhibits a quantifiable increased
aggressive phenotype compared to wild-type controls and our knock-in mouse HD model mice.
This aggressive phenotype appears to indicate that HD related aggression is an overreaction to
threatening stimuli, which has furthered our understanding of HD-related aggression as a
reactive form of aggression. Using our humanized HD model, which recapitulates HD-related
aggression, we can elucidate the neurological changes that can correlate to this heightened
aggressive phenotype and identify neurological targets for therapeutics to reduce aggressive
behavioral symptoms in HD patients.

19

REFERENCES
1.

2.
3.
4.
5.
6.
7.
8.

9.
10.
11.

12.

13.
14.
15.

16.

17.

A novel gene containing a trinucleotide repeat that is expanded and unstable on
Huntington's disease chromosomes. The Huntington's Disease Collaborative Research
Group. Cell, 1993. 72(6): p. 971-83.
Julien, C.L., et al., Psychiatric disorders in preclinical Huntington's disease. J Neurol
Neurosurg Psychiatry, 2007. 78(9): p. 939-43.
Eddy, C.M., E.G. Parkinson, and H.E. Rickards, Changes in mental state and behaviour
in Huntington's disease. Lancet Psychiatry, 2016. 3(11): p. 1079-1086.
Ready, R.E., et al., Patient and caregiver quality of life in Huntington's disease. Mov
Disord, 2008. 23(5): p. 721-6.
Siever, L.J., Neurobiology of Aggression and Violence. The American journal of
psychiatry, 2008. 165(4): p. 429-442.
Shiwach, R.S. and V. Patel, Aggressive behaviour in Huntington's disease: a crosssectional study in a nursing home population. Behav Neurol, 1993. 6(1): p. 43-7.
Fisher, C.A., et al., Aggression in Huntington's disease: a systematic review of rates of
aggression and treatment methods. J Huntingtons Dis, 2014. 3(4): p. 319-32.
Brown, A., K. Sewell, and C.A. Fisher, Characterisation of aggression in Huntington's
disease: rates, types and antecedents in an inpatient rehabilitation setting. 2017. 26(1920): p. 2922-2931.
Petersen, A. and S. Gabery, Hypothalamic and Limbic System Changes in Huntington's
Disease. J Huntingtons Dis, 2012. 1(1): p. 5-16.
Soneson, C., et al., Early changes in the hypothalamic region in prodromal Huntington
disease revealed by MRI analysis. Neurobiol Dis, 2010. 40(3): p. 531-43.
Ahveninen, L.M., et al., Reduced amygdala volumes are related to motor and cognitive
signs in Huntington's disease: The IMAGE-HD study. Neuroimage Clin, 2018. 18: p.
881-887.
Douaud, G., et al., Distribution of grey matter atrophy in Huntington's disease patients: a
combined ROI-based and voxel-based morphometric study. Neuroimage, 2006. 32(4): p.
1562-75.
Hashikawa, Y., et al., Ventromedial Hypothalamus and the Generation of Aggression.
Front Syst Neurosci, 2017. 11: p. 94.
Coccaro, E.F., et al., Amygdala and orbitofrontal reactivity to social threat in individuals
with impulsive aggression. Biol Psychiatry, 2007. 62(2): p. 168-78.
Dougherty, D.D., et al., Ventromedial prefrontal cortex and amygdala dysfunction during
an anger induction positron emission tomography study in patients with major depressive
disorder with anger attacks. Arch Gen Psychiatry, 2004. 61(8): p. 795-804.
Wang, Y., et al., Medial amygdala lesions modify aggressive behavior and immediate
early gene expression in oxytocin and vasopressin neurons during intermale exposure.
Behavioural Brain Research, 2013. 245: p. 42-49.
Van den Stock, J., et al., Functional brain changes underlying irritability in premanifest
Huntington's disease. HUMAN BRAIN MAPPING, 2015. 36(7): p. 2681-2690.

20

18.
19.
20.
21.
22.
23.
24.

25.
26.
27.

28.

29.

Klöppel, S., et al., Irritability in pre-clinical Huntington's disease. Neuropsychologia,
2010. 48(2): p. 549-57.
Falkner, A.L., et al., Decoding ventromedial hypothalamic neural activity during male
mouse aggression. J Neurosci, 2014. 34(17): p. 5971-84.
Tonkonogy, J.M. and J.L. Geller, Hypothalamic lesions and intermittent explosive
disorder. J Neuropsychiatry Clin Neurosci, 1992. 4(1): p. 45-50.
Olivier, B., The ventromedial hypothalamus and aggressive behaviour in rats.
Aggressive Behavior, 1977. 3(1): p. 47-56.
Falkner, A.L., et al., Hypothalamic control of male aggression-seeking behavior. Nat
Neurosci, 2016. 19(4): p. 596-604.
Southwell, A.L., et al., A fully humanized transgenic mouse model of Huntington disease.
Hum Mol Genet, 2013. 22(1): p. 18-34.
Southwell, A.L., et al., An enhanced Q175 knock-in mouse model of Huntington disease
with higher mutant huntingtin levels and accelerated disease phenotypes. Hum Mol
Genet, 2016. 25(17): p. 3654-3675.
Watson, C., G. Paxinos, and H. Tokuno, Using a panel of immunomarkers to define
homologies in mammalian brains. Frontiers in Human Neuroscience, 2010. 4(13).
Moreno, N. and A. Gonzalez, Central amygdala in anuran amphibians: neurochemical
organization and connectivity. (0021-9967 (Print)).
Dugger, B.N., et al., Androgen receptors are required for full masculinization of the
ventromedial hypothalamus (VMH) in rats. Hormones and Behavior, 2007. 51(2): p. 195201.
KIDDRC Histology Services. Thionin staining for frozen tissues. 2018, July 28;
Available from: http://www.kumc.edu/Documents/siddrc/Thionin-Staining-frozentissues.pdf.
Goelz, M.F., et al., Neuropathologic findings associated with seizures in FVB mice. Lab
Anim Sci, 1998. 48(1): p. 34-7.

21

